The stock of Ventas, Inc. (NYSE:VTR) gapped down by $0.19 today and has $62.96 target or 9.00% below today’s $69.19 share price. The 8 months technical chart setup indicates high risk for the $24.58B company. The gap down was reported on Oct, 4 by Barchart.com. If the $62.96 price target is reached, the company will be worth $2.21B less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock decreased 2.04% or $1.44 on October 3, hitting $69.19. Ventas, Inc. (NYSE:VTR) has risen 20.18% since March 1, 2016 and is uptrending. It has outperformed by 7.97% the S&P500.
Analysts await Ventas, Inc. (NYSE:VTR) to report earnings on October, 28. They expect $1.01 EPS, down 7.34% or $0.08 from last year’s $1.09 per share. VTR’s profit will be $358.81M for 17.13 P/E if the $1.01 EPS becomes a reality. After $1.04 actual EPS reported by Ventas, Inc. for the previous quarter, Wall Street now forecasts -2.88% negative EPS growth.
Ventas, Inc. (NYSE:VTR) Ratings Coverage
Out of 10 analysts covering Ventas Inc. (NYSE:VTR), 0 rate it a “Buy”, 0 “Sell”, while 10 “Hold”. This means 0 are positive. Ventas Inc. has been the topic of 26 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The stock has “Neutral” rating given by Mizuho on Monday, October 26. The company was maintained on Friday, September 4 by Mizuho. The stock of Ventas, Inc. (NYSE:VTR) has “Neutral” rating given on Friday, May 20 by UBS. Argus Research initiated Ventas, Inc. (NYSE:VTR) on Wednesday, July 13 with “Hold” rating. On Thursday, January 14 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. The stock has “Outperform” rating given by BMO Capital Markets on Monday, July 27. Stifel Nicolaus downgraded Ventas, Inc. (NYSE:VTR) on Tuesday, February 16 to “Hold” rating. The firm has “Neutral” rating by BTIG Research given on Thursday, August 25. The rating was downgraded by Goldman Sachs to “Neutral” on Thursday, March 24. On Wednesday, January 6 the stock rating was initiated by Barclays Capital with “Equal-Weight”.
According to Zacks Investment Research, “Ventas, Inc. is a healthcare real estate investment trust.”
Insitutional Activity: The institutional sentiment decreased to 1.26 in Q2 2016. Its down 0.34, from 1.6 in 2016Q1. The ratio dropped, as 40 funds sold all Ventas, Inc. shares owned while 189 reduced positions. 58 funds bought stakes while 231 increased positions. They now own 309.67 million shares or 1.99% less from 315.96 million shares in 2016Q1.
Geode Capital Mngmt Ltd Liability last reported 3.21 million shares in the company. Moreover, Aston Asset Mgmt Limited Co has 1.1% invested in Ventas, Inc. (NYSE:VTR) for 24,732 shares. Us Bank De last reported 44,140 shares in the company. Canada Pension Plan Investment Board holds 6,138 shares or 0% of its portfolio. State Of Tennessee Treasury Department holds 0.03% or 75,814 shares in its portfolio. Glob X Mgmt Ltd Co accumulated 0.02% or 4,693 shares. Capwealth Ltd Co, a Tennessee-based fund reported 546 shares. Nationwide Fund Advsrs reported 220,012 shares or 0.07% of all its holdings. Honeywell Interest has invested 0.16% of its portfolio in Ventas, Inc. (NYSE:VTR). Ngam Advsrs Ltd Partnership accumulated 187,743 shares or 0.19% of the stock. National Asset Mngmt accumulated 0.09% or 6,007 shares. Blackrock Management holds 0.08% or 817,965 shares in its portfolio. Hirtle Callaghan & Co Lc has invested 0.05% of its portfolio in Ventas, Inc. (NYSE:VTR). New Mexico Educational Retirement Board holds 0.29% of its portfolio in Ventas, Inc. (NYSE:VTR) for 87,179 shares. Ls Invest Advisors Lc has 0.06% invested in the company for 11,187 shares.
Insider Transactions: Since August 2, 2016, the stock had 0 insider purchases, and 4 sales for $18.19 million net activity. CAFARO DEBRA A sold $807,562 worth of Ventas, Inc. (NYSE:VTR) on Friday, August 12. Shares for $12.37M were sold by RINEY T RICHARD on Tuesday, August 16. The insider Cobb John D. sold 60,000 shares worth $4.50 million. 6,943 shares were sold by Liebbe Gregory R, worth $508,225.
Another recent and important Ventas, Inc. (NYSE:VTR) news was published by Forbes.com which published an article titled: “Ex-Dividend Reminder: Comerica, Ventas and RenaissanceRe Holdings” on September 09, 2016.
VTR Company Profile
Ventas, Inc., incorporated on June 22, 1987, is a healthcare real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Firm operates through three divisions: triple-net leased properties, senior living activities and medical office building (MOB) operations. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom. Through its senior living activities segment, the Company invests in seniors housing communities throughout the United States and Canada, and engages independent operators to manage approximately 304 of its seniors housing communities. In its MOB activities segment, the Company primarily acquires, owns, develops, leases and manages MOBs. The Firm primarily invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operates them through independent third-party managers. It leases approximately 575 properties to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.